If you need any product or service please register as the Farmavita.Net network member and publish your needs.
License-in is very cost effective way of product development. In the most of the licensing cases you will pay only share of total development cost for the pharmaceutical product.
Published license-out opportunities are alphabetically listed according to pharmaceutical INN name.
Please choose the category below:
I have two promising novel classes of anticancer drugs with first in class attributes available for in licensing.
The Non Proteolytic Proteasome Inhibitor demonstrated a Proteasome inhibition through a novel mechanism/target. This compound is currently at the lead generation stage.
POC : In-vitro cytotoxicactivity on human cancer cells